The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer

BACKGROUND: CDCP1, a transmembrane protein with tumor pro-metastatic activity, was recently identified as a prognostic marker in TNBC, the most aggressive breast cancer subtype still lacking an effective molecular targeted therapy. The mechanisms driving CDCP1 over-expression are not fully understoo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Forte, Luca, Turdo, Federica, Ghirelli, Cristina, Aiello, Piera, Casalini, Patrizia, Iorio, Marilena Valeria, D’Ippolito, Elvira, Gasparini, Patrizia, Agresti, Roberto, Belmonte, Beatrice, Sozzi, Gabriella, Sfondrini, Lucia, Tagliabue, Elda, Campiglio, Manuela, Bianchi, Francesca
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5967041/
https://ncbi.nlm.nih.gov/pubmed/29792166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4500-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars